Literature DB >> 9632845

Progesterone receptor A and B isoform expression in human osteoblasts.

P Mac Namara1, H C Loughrey.   

Abstract

We have previously shown that human progesterone receptors (PR) are expressed in human osteosarcoma cells and in primary human osteoblast cultures. The aim of this study was to examine PRa and PRb isoform expression in human osteosarcoma cells. In addition, the effect of beta-estradiol on PR promoter activity in three human osteosarcoma cell lines was analyzed. Rapid amplification of 5'cDNA ends (5'RACE) were used to detect PR mRNA transcripts coding for both PR isoforms in HOS-TE85, an early progenitor human osteosarcoma cell line. Analogous 5'RACE products were detected in the PR-positive breast-cancer cell line MCF-7. Southern blot analysis confirmed that the amplified products were PR specific. It was shown that the larger of two RACE products coded specifically for B isoform mRNA and that of the smaller product corresponded to a PRa specific transcript. No RACE products were detected in the PR-negative HeLa cell line. To determine if both PR promoters were active in osteoblasts, chimeric recombinants bearing the PRa (+464, +1105) and PRb (-711, +31) promoter regions subcloned into minimal pBLCAT vectors, were transiently expressed in three human osteosarcoma cell lines-HOS-TE85, MG-63, and SAOS-2. It was shown that beta-estradiol induced both PRa and PRb promoter activity in all of the osteosarcoma cell lines examined. The finding that PRa and PRb mRNA transcripts are expressed in human osteoblasts, and that promoters for both isoforms are estrogen responsive provides further evidence that bone-forming cells are physiologically influenced by progesterone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632845     DOI: 10.1007/s002239900487

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  3 in total

1.  A truncated progesterone receptor (PR-M) localizes to the mitochondrion and controls cellular respiration.

Authors:  Qunsheng Dai; Anish A Shah; Rachana V Garde; Bryan A Yonish; Li Zhang; Neil A Medvitz; Sara E Miller; Elizabeth L Hansen; Carrie N Dunn; Thomas M Price
Journal:  Mol Endocrinol       Date:  2013-03-21

Review 2.  Postmenopausal tibolone therapy: biologic principles and applied clinical practice.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2007-01-03

3.  Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.

Authors:  Wei Yao; Weiwei Dai; Mohammad Shahnazari; Aaron Pham; Zhiqiang Chen; Haiyan Chen; Min Guan; Nancy E Lane
Journal:  PLoS One       Date:  2010-07-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.